TRUP Logo

Trupanion, Inc. (TRUP) 

NASDAQ
Market Cap
$2.15B
Sector
Financial Services
Industry
Insurance—Specialty
Rank in Sector
89 of 647
Rank in Industry
2 of 20

Largest Insider Buys in Sector

TRUP Stock Price History Chart

TRUP Stock Performance

About Trupanion, Inc.

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Insider Activity of Trupanion, Inc.

Over the last 12 months, insiders at Trupanion, Inc. have bought $499,663 and sold $2.43M worth of Trupanion, Inc. stock.

On average, over the past 5 years, insiders at Trupanion, Inc. have bought $1.14M and sold $24.64M worth of stock each year.

Highest buying activity among insiders over the last 12 months: RAWLINGS DARRYL (Chief Executive Officer) — $499,663.

The last purchase of 20,700 shares for transaction amount of $499,663 was made by RAWLINGS DARRYL (Chief Executive Officer) on 2024‑05‑07.

List of Insider Buy and Sell Transactions, Trupanion, Inc.

2024-11-29SaleChief Financial Officer
9,867
0.0232%
$53.08$523,789+0.86%
2024-11-26SaleChief Financial Officer
622
0.0014%
$52.61$32,723-1.29%
2024-11-25SaleSVP, Channel Growth
900
0.0021%
$54.55$49,095+0.47%
2024-11-22SaleSVP, Channel Growth
3,100
0.0075%
$54.85$170,038+0.09%
2024-11-21SaleEVP, North Am & Vet Strategy
11,916
0.028%
$53.00$631,548+1.85%
2024-11-20SaleCEO
5,000
0.0119%
$52.00$260,007+3.44%
2024-11-06Saledirector
2,000
0.005%
$52.67$105,347+6.47%
2024-11-04SaleGeneral Manager
2,000
0.0049%
$52.72$105,449+6.81%
2024-08-28SaleCEO
7,500
0.0178%
$46.48$348,600+8.98%
2024-08-26SaleChief Financial Officer
624
0.0014%
$46.54$29,041+4.01%
2024-08-16SaleChief Financial Officer
640
0.0017%
$43.12$27,597+0.49%
2024-05-30SaleEVP, North Am & Vet Strategy
1,000
0.0023%
$29.35$29,350+50.15%
2024-05-30SaleGeneral Manager
1,200
0.0029%
$30.04$36,054+50.15%
2024-05-07SaleSVP, Channel Growth
3,125
0.0084%
$25.34$79,201+69.24%
2024-05-07PurchaseChief Executive Officer
20,700
0.0531%
$24.14$499,663+69.24%
2023-11-30SaleEVP, North Am & Vet Strategy
10,170
0.025%
$26.11$265,518+13.77%
2023-11-30SaleGeneral Manager
1,213
0.003%
$26.27$31,866+13.77%
2023-08-30Saledirector
8,688
0.0209%
$29.99$260,522-7.20%
2023-05-08SaleChief Executive Officer
4,000
0.0096%
$25.30$101,188+5.36%
2023-04-19SaleChief Executive Officer
4,000
0.0097%
$35.48$141,920-23.74%

Insider Historical Profitability

11.79%
RAWLINGS DARRYLChief Executive Officer
614842
1.452%
$50.731170
Ferracone Robin Adirector
51056
0.1206%
$50.7382+21.69%
NOVOTNY GLENN Wdirector
18974
0.0448%
$50.7322<0.0001%
DAVIDSON JACQUELINE Ldirector
1000
0.0024%
$50.7310+18.48%
Wolff Andrew D.Chief Financial Officer
779
0.0018%
$50.7320<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$160.29M13.825.81M-2.32%-$3.81M<0.01
Capital World Investors$111M9.574.02M0%+$00.02
The Vanguard Group$101.43M8.743.67M+0.89%+$896,910.84<0.01
Aflac$100.4M8.653.64M0%+$098.34
Flossbach von Storch$79.52M6.852.88M0%+$00.35
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.